- Start
- Isocitrate Dehydrogenase Inhibitors in Cancer Chemotherapy: Volume 20
Isocitrate Dehydrogenase Inhibitors in Cancer Chemotherapy: Volume 20
Angebote / Angebote:
Isocitrate Dehydrogenase Inhibitors in Cancer Chemotherapy presents an in-depth and up-to-date compilation of research on isocitrate dehydrogenase as drug target to be used as a sensitizing agent in chemotherapy. The book brings a combination of medicinal, biological and chemical points-of-view to fully cover the subject. It discusses topics such as IDH place in cellular metabolism, mutant IDH as drug target, mono- and poli-therapies based on IDH1/2 inhibitors, and IDH1/2 inhibitors in leukemia, gliomas and other brain tumors, and potential importance in gastrointestinal cancers. Additionally, it discusses isocitrate dehydrogenases as target for theranostics, therapeutic strategies and future perspectives. This is a valuable resource for cancer researchers, oncologists and members of the biomedical field who are interested to learn more about IDH inhibitors and their potential as sensitizing agents for chemotherapy.
Fremdlagertitel. Lieferzeit unbestimmt
Preis
195,00 CHFVerfügbarkeit:
LieferbarArtikel, die Sie kürzlich angesehen haben
Fremdlagertitel. Lieferzeit unbestimmt
Fremdlagertitel. Lieferzeit unbestimmt
Fremdlagertitel. Lieferzeit unbestimmt